Cochlear is now under Algo Engine buy conditions and has been added into our ASX 100 model portfolio.
Whilst the FY19 result came in at the bottom end of guidance, the company upgraded the FY20 outlook. We now expect 10% EPS growth over the next 12 months.
You're not a member! Trial today
The stock remains expensive at 40x FY20 earnings and trading on a 1.8% yield.
